Stroke and Anxiety Reduction
Acute Stroke
About this trial
This is an interventional supportive care trial for Acute Stroke
Eligibility Criteria
Inclusion Criteria: Be diagnosed with an acute stroke Able to speak, read and write in English Not cognitively impaired, as per standard of care documentation in the EHR regarding mental status. Discharged to home Internet access including email Willingness to participate in an anxiety reduction program Length of hospital stay less than 5 days from the initial presentation of stroke symptoms Must be medically stable Exclusion Criteria: Not diagnosed with an acute stroke Unable to speak, read and write in English as this intervention is not available in other languages and at this time, funding is not available in order to have the resources provided translated or to have translation services available for these participants. Not discharged to home No internet access including email Unwilling or unable to participate in an anxiety reduction program Cognitively impaired Length of hospital stay greater than 6 days from the initial presentation of stroke symptoms Not medically stable
Sites / Locations
- NYU Langone Health
Arms of the Study
Arm 1
Experimental
Patients discharged following acute care stroke
Participation will last 3 months from enrollment. Demographic data will be retrieved from the electronic health record and the Generalized Anxiety Disorder-7 (GAD-7) Anxiety Questionnaire will be administered at baseline. Participants will repeat the GAD-7 in 3 months and an additional qualitative survey on their experience including an evaluation of the structured anxiety reduction program.